| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely benzocaine 10 milligram/1 milliliter and triclosan 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Bentoquatam 50 mg/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| ammoniumlaktat 1 %, lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely urea 100 milligram/1 gram conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely crotamiton 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| betametason 0,1 %, lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Mometasone furoate 1 mg/g cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Coal tar 10 mg/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Allantoin 20 mg/g and coal tar extract 50 mg/g cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Tretinoin 250 microgram/g cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Benzoyl peroxide 100 mg/g cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely salicylic acid 20 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely phenothrin 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Aluminium acetate 6.5 mg/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| sulfacetamid 10 %, lösning |
Has manufactured dose form |
False |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely metronidazole 7.5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely desonide 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| hydrokortison 2 %, lotion för lokalt bruk |
Has manufactured dose form |
False |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| klindamycinfosfat 10 milligram/milliliter, hudlotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone 5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Selenium sulfide 25 mg/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Urea 400 mg/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely amphotericin B 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| hydrokortison 2,5 %, lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Hydrocortisone 10 mg/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| betametasondipropionat 0,05 %, lotion |
Has manufactured dose form |
False |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Clotrimazole 10 mg/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone 25 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Fludroxycortide 500 microgram/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely methoxsalen 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Clobetasol propionate 500 microgram/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Amcinonide 1 mg/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely fluticasone propionate 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Triamcinolone acetonide 1 mg/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely benzyl alcohol 50 microliter/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Hydrocortisone butyrate 1 mg/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely malathion 5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Adapalene 1 mg/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Carbaryl 5 mg/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Tetracycline 10 mg/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely ciclopirox (as ciclopirox olamine) 7.7 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Hydrocortisone acetate 20 mg/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely coal tar 400 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely betamethasone valerate 1 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely coal tar 40 milligram/1 milliliter and ketoconazole 20 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Lindane 10 mg/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely calamine 150 milligram/1 milliliter and zinc oxide 50 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|
| Betamethasone (as betamethasone dipropionate) 500 microgram/mL and salicylic acid 30 mg/mL cutaneous lotion |
Has manufactured dose form |
True |
Conventional release cutaneous lotion (dose form) |
Inferred relationship |
Some |
|